Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients

August 21, 2025

View Press Release Corporate presentation Contact us
Previous